Invesco’s Hemab Therapeutics COAG Stock Holding History
Bought
Maintained
Sold
Other funds holding COAG
SL
Invesco's COAG Position: Q3 2026 in Review
Invesco opened a new position in Hemab Therapeutics (COAG) in Q3 2026: 9,215 shares worth $284K. The stake represents ﹤0.01% of the portfolio and ranks #3472 among its holdings.
89 funds tracked by Wall St. Rank hold COAG as of Q3 2026.
- Invesco held 9,215 shares of Hemab Therapeutics worth $284K as of Q3 2026.
- Hemab Therapeutics was a new Invesco position in Q3 2026.
- Hemab Therapeutics made up ﹤0.01% of Invesco's portfolio in Q3 2026, its #3472 holding.
- 89 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q3 2026.
Based on Invesco's 13F filing for Q3 2026, filed 12 Nov 2026.